1. Caner B, Kitapcl M, Unlu M, Erbengi G, Calikoglu T, Gogus T. Technetium-99m-MIBI uptake in benign and malignant bone lesions: a comparative study with technetium-99m-MDP. J Nucl Med. 1992;33:319–24.
2. Chamarthy M, Travin MI. Altered biodistribution and incidental findings on myocardial perfusion imaging. Semin Nucl Med. 2010;40:257–70.
3. Fisher C, Vehec A, Kashlan B, Longa G, Houpt L, Howe K, Stark L, Cavanaugh D. Incidental detection of skeletal uptake on sestamibi cardiac imaging in a patient with previously undiagnosed multiple myeloma. Clin Nucl Med. 2000;25:213–4.
4. Gowda A, Peddinghaus L, Shandilya V, Gavriluke A, Jain D. Abnormal intense skeletal radiotracer uptake on myocardial perfusion imaging with Tc-99m sestamibi. J Nucl Cardiol. 2006;13:427–31.
5. Mariani G, Filocamo M, Giona F, Villa G, Amendola A, Erba P, Buffoni F, Copello F, Pierini A, Minichilli F, Gatti R, Brady RO. Severity of bone marrow involvement in patients with Gaucher’s disease evaluated by scintigraphy with 99mTc-sestamibi. J Nucl Med. 2003;44:1253–62.